Protego Biopharma
San Diego, US · Delaware corporation
BiotechHealthtech
Founders & leadership
BJ
Brent J. WarnerExecutive
XJ
XIN JIANGPresident & CEO
HM
HANK MICHAEL PETRASSINamed on SEC filing
JK
JEFFERY KELLYNamed on SEC filing
Board
TL
TIM LOHOFFBoard director
EH
EDWARD HURWITZBoard director
JN
JANWILLEM NAESENSBoard director
SB
SAOUSSEN BEN HALIMABoard director
LB
LAURA BRASSBoard director
SC
SHELLEY CHUBoard director
EH
Edward HurwitzInvestor
RL
Richard LabaudiniereChairman of the Board of Directors
Reported raises · per SEC filings
Form D private placements$85M disclosed across 3 rounds · 2019–2025
▶$32.9MraisedDec 2025 · 18 investors · Other Health CareRule 506(b)
▶$32.9MraisedDec 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- TIM LOHOFFDirector
- EDWARD HURWITZDirector
- HANK MICHAEL PETRASSIExecutive Officer
- JANWILLEM NAESENSDirector
- SAOUSSEN BEN HALIMADirector
- LAURA BRASSDirector
- JEFFERY KELLYDirector
- Brent J. WarnerExecutive Officer, Director
- SHELLEY CHUDirector
- HELEN KIMDirector
- Offering amount
- $130.4M
- Amount sold
- $32.9M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$51MraisedOct 2021 · 6 investors · BiotechnologyRule 506(b)
▶$51MraisedOct 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard LabaudiniereExecutive Officer, Director
- Jeffrey KellyDirector
- Edward HurwitzDirector
- Shelley ChuDirector
- Helen KimDirector
- Offering amount
- $51M
- Amount sold
- $51M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedDec 2019 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- XIN JIANGExecutive Officer
- Edward HurwitzDirector
- Jeffery W KellyPromoter
- Richard LabaudiniereDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04, 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Protego Biopharma raised?
- Protego Biopharma has disclosed $85M raised across 3 rounds.
- Where is Protego Biopharma headquartered?
- Protego Biopharma is headquartered in San Diego, US.